RecallGuardianCanada
Health products· Updated May 5, 2023

Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) due to possible device failure

Critical priority
Recalled product: Bausch Health, Canada Inc. recalls all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) due to possible device failure
What you should do
  1. 1Consult your pharmacist to ensure you understand how to properly use the replacement auto-injector.
  2. 2In the event a life-threatening allergic reaction (anaphylaxis) occurs before you can obtain a replacement auto-injector, use your Emerade device and then seek emergency medical attention.
  3. 3Speak with your healthcare professional if you are concerned about your health.
  4. 4Contact Bausch Health, Canada Inc. by calling 1-800-361-4261, or emailing canada.customerservice@bauschhealth.com , if you have questions about the recall.
  5. 5Report any health product-related side effects or complaints to Health Canada.
The issue

Other

Affected product

Emerade epinephrine auto-injectors, 0.3 mg (DIN 02458446) and 0.5 mg (DIN 02458454)

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls